//
Randomized Comparison of Ridaforolimus-Eluting and Zotarolimus-Eluting Coronary Stents 2-Year Clinical Outcomes: From the BIONICS and NIREUS Trials
Microthrombi As A Major Cause of Cardiac Injury in COVID-19: A Pathologic Study
Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial
Qualitative and Mixed Methods Provide Unique Contributions to Outcomes Research
How Low to Go With Glucose, Cholesterol, and Blood Pressure in Primary Prevention of CVD
Safety and feasibility of robotic percutaneous coronary intervention: PRECISE (Percutaneous Robotically-Enhanced Coronary Intervention) Study
Major infections after bypass surgery and stenting: an overlooked but fatal complication
Sudden Cardiac Arrest Survivorship: A Scientific Statement From the American Heart Association